Biography
Dr. Nezami is a board certified physician graduated from USC and UCSF residencies. He has functioned as a faculty teacher during his training as well as invited presenter at society of teachers in Family medicine. He has been in practice for 18 years and currently is the president of Pacific Medical Center of Hope in California. He is promoting research in conventional oncology, in cutting edge. Dr Nezami serves as national and international speaker in oncology and epigenetic science. He has been involved in many research projects and publications, presentations ( including integrative medicine, Epigenetic therapies 2013 Barcelona Conference on Epigenetics and Cancer, Society of integrative oncology, American Association for Cancer Research ( AACR), Molecular Medicine Triconference, World Molecular Imaging, and World Pharmaceutical Congress, NCI-AACR, .... Author, Integrative Medicine, A Clinician Journal, as well as author and coauthor in oncology literature. (Surveillance in lymphoma, published 2006, Cancer Science 2015, JCT 2015, 2016, Precision medicine,.....). He is a co author of Weil’s " Textbook for integrative oncology
Research Interest
Cancer
Biography
Dharanipathy Rangaraj has completed his PhD from University of Missouri, Columbia.He is Board Certified Medical Physicist.He has published more than 25 papers in reputed journals and has been serving as an editorial board member of repute
Research Interest
Radiation Oncology
Biography
Bogusław Maciejewski has completed his PhD at the age of 32 years and scientific title of a full professor in radiotherapy being 45 years old. He realized research projects in the UCLA Los Angeles, Gray Lab London, MGH Harvard Univ. Boston, MDACC Houston and other cancer centers in Europe. He was the director of Cancer Center – Institute Gliwice, Poland for 24 years, till 2015. He is author of over 200 papers published in reputed journals (IF = 1650, citation index = 3500). He awarded G.F. Fletcher Gold Medal, Gold Medal of Life Achievements in Oncology given by all European oncologic societies as he is a honorary member of American College of Radiology, radiotherapy expert of the IAEA in Vienna and for 10 years he was a member of European Board of Radiotherapy participating in the development European curriculum for radiotherapy. His major scientic interest is importance of treatment time and tumor repopulation and altered dose fractionation in clinical radiotherapy for human tumors.
Research Interest
Radiotherapy